首页 > 最新文献

Danish medical bulletin最新文献

英文 中文
Impact of new advances in sex research on psychoanalytic theory. 性研究的新进展对精神分析理论的影响。
Pub Date : 2018-05-30 DOI: 10.4324/9780429478215-2
R. Stoller
{"title":"Impact of new advances in sex research on psychoanalytic theory.","authors":"R. Stoller","doi":"10.4324/9780429478215-2","DOIUrl":"https://doi.org/10.4324/9780429478215-2","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"19 8 1","pages":"287-301"},"PeriodicalIF":0.0,"publicationDate":"2018-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41322633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Global Mental Health : Anthropological Perspectives 全球心理健康:人类学视角
Pub Date : 2016-07-01 DOI: 10.4324/9781315428055
B. Kohrt, Emily Mendenhall
{"title":"Global Mental Health : Anthropological Perspectives","authors":"B. Kohrt, Emily Mendenhall","doi":"10.4324/9781315428055","DOIUrl":"https://doi.org/10.4324/9781315428055","url":null,"abstract":"","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70646642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes. 50-65岁丹麦人对带状疱疹的认识和对带状疱疹疫苗接种的态度。
Pub Date : 2011-12-01
Gitte Lee Mortensen

Introduction: Herpes zoster (HZ or shingles) and its complication post-herpetic neuralgia (PHN) are common in persons above 50 years of age. A vaccine that decreases the incidence and morbidity associated with HZ was licensed for use in 2006 and will be marketed in Denmark as from 2013. This study aimed to explore the relations between illness perceptions of shingles and attitudes towards zoster vaccination.

Material and methods: Three qualitative focus group interviews were conducted with 22 patients, relatives and individuals with no personal experiences with HZ. Semi-structured interview guides were applied including questions identified in a literature study. The data were analysed using a medical anthropological approach.

Results: The study showed that HZ and PHN, in particular, have severe impacts on patients' quality of life (QoL) and often affect their relatives' daily lives as well. Nevertheless, people who have no experience with HZ underrate both its prevalence and its QoL impacts. Such misperceptions often result in delayed treatment and may lead to a low uptake of zoster vaccination.

Conclusion: Individual attitudes towards zoster vaccination are closely related to subjective perceptions of HZ and views on vaccination in general. Vaccination recommendations to target groups are necessary, but individual choice is determined by knowledge about the disease, personal risk assessment and the recommendations of the general practitioner.

Funding: The study was funded by a research grant from Sanofi Pasteur MSD.

Trial registration: not relevant.

简介:带状疱疹(HZ或带状疱疹)及其并发症带状疱疹后神经痛(PHN)常见于50岁以上人群。一种降低HZ相关发病率和发病率的疫苗于2006年获得使用许可,并将于2013年在丹麦上市。本研究旨在探讨带状疱疹疾病认知与带状疱疹疫苗接种态度之间的关系。材料与方法:采用3次定性焦点小组访谈法对22名患者、家属和无HZ个人经历的个体进行访谈。采用半结构化访谈指南,包括在文献研究中确定的问题。使用医学人类学方法对数据进行了分析。结果:研究表明,尤其是HZ和PHN对患者的生活质量(QoL)有严重影响,并经常影响其亲属的日常生活。然而,没有HZ经历的人低估了其患病率和对生活质量的影响。这种误解往往导致延误治疗,并可能导致带状疱疹疫苗接种率低。结论:个体对带状疱疹疫苗接种的态度与对HZ的主观认知和对一般疫苗接种的看法密切相关。对目标人群的疫苗接种建议是必要的,但个人的选择取决于对疾病的了解、个人风险评估和全科医生的建议。资助:本研究由赛诺菲巴斯德MSD的研究资助。试验注册:不相关。
{"title":"Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes.","authors":"Gitte Lee Mortensen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Herpes zoster (HZ or shingles) and its complication post-herpetic neuralgia (PHN) are common in persons above 50 years of age. A vaccine that decreases the incidence and morbidity associated with HZ was licensed for use in 2006 and will be marketed in Denmark as from 2013. This study aimed to explore the relations between illness perceptions of shingles and attitudes towards zoster vaccination.</p><p><strong>Material and methods: </strong>Three qualitative focus group interviews were conducted with 22 patients, relatives and individuals with no personal experiences with HZ. Semi-structured interview guides were applied including questions identified in a literature study. The data were analysed using a medical anthropological approach.</p><p><strong>Results: </strong>The study showed that HZ and PHN, in particular, have severe impacts on patients' quality of life (QoL) and often affect their relatives' daily lives as well. Nevertheless, people who have no experience with HZ underrate both its prevalence and its QoL impacts. Such misperceptions often result in delayed treatment and may lead to a low uptake of zoster vaccination.</p><p><strong>Conclusion: </strong>Individual attitudes towards zoster vaccination are closely related to subjective perceptions of HZ and views on vaccination in general. Vaccination recommendations to target groups are necessary, but individual choice is determined by knowledge about the disease, personal risk assessment and the recommendations of the general practitioner.</p><p><strong>Funding: </strong>The study was funded by a research grant from Sanofi Pasteur MSD.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"A4345"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-dose drug dispensing is a challenge across the primary-secondary care interface. 多剂量药物调剂是整个初级和二级保健界面的一个挑战。
Pub Date : 2011-12-01
Lene Orskov Reuther, Charlotte Lysen, Mette Faxholm, Lena Salomon, Carsten Hendriksen

Introduction: Multi-dose drug dispensing (MDDD) signifies that the patient's medicine is packed in disposable bags corresponding to the dose that should be taken. The purpose of the present study was to investigate how a hospital MDDD instruction was followed.

Material and methods: All patients receiving MDDD on admission to the acute medical admission ward at Bispebjerg Hospital in the period from 1 January to 30 June 2010 were prospectively included in the study. An audit of the medication lists and hospital case records covering the period from admission to discharge was performed. A proportion of patients received a post-discharge home visit. An interview in both sectors was carried out to determine whether the instructions had been followed.

Results: Almost 9% of the patients were receiving MDDD on admission. Information on MDDD was recorded in the physician case record for 3.4% of the patients and in the nurse case record for 12.9% of the patients. Changes in MDDD during hospitalization were made for 58.3% of the patients. General practitioners and/or the community pharmacy were notified of changes in MDDD at discharge for 13.6% of the patients. The post-discharge visits and the interview revealed potential issues of concern regarding patient safety.

Conclusion: MDDD is frequent. Identification and registration of MDDD is only performed sporadically. Changes in MDDD are frequent, but they are rarely accompanied by information to the general practitioner or the community pharmacy.

Funding: The project was partly funded by the Ministry of Health and Prevention 2009.

Trial registration: The study was approved by the Danish Data Protection Agency.

多剂量药物调剂(MDDD)是指患者的药物被包装在与应服用剂量相对应的一次性袋中。本研究旨在探讨医院MDDD的执行情况。材料和方法:2010年1月1日至6月30日期间,所有在比斯堡医院急症住院病房接受MDDD治疗的患者被前瞻性纳入研究。对从入院到出院期间的药物清单和医院病例记录进行了审计。一定比例的患者接受出院后家访。在这两个部门进行了一次面谈,以确定指示是否得到遵守。结果:近9%的患者在入院时接受MDDD治疗。3.4%的患者在医生病例记录中记录了MDDD信息,12.9%的患者在护士病例记录中记录了MDDD信息。住院期间MDDD发生变化的患者占58.3%。13.6%的患者出院时,全科医生和/或社区药房被告知MDDD的变化。出院后访问和访谈揭示了患者安全方面的潜在问题。结论:MDDD较为常见。MDDD的识别和注册只是偶尔进行。MDDD的变化是频繁的,但它们很少伴随向全科医生或社区药房的信息。资金:该项目部分资金由2009年卫生和预防部提供。试验注册:该研究已获得丹麦数据保护局的批准。
{"title":"Multi-dose drug dispensing is a challenge across the primary-secondary care interface.","authors":"Lene Orskov Reuther,&nbsp;Charlotte Lysen,&nbsp;Mette Faxholm,&nbsp;Lena Salomon,&nbsp;Carsten Hendriksen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Multi-dose drug dispensing (MDDD) signifies that the patient's medicine is packed in disposable bags corresponding to the dose that should be taken. The purpose of the present study was to investigate how a hospital MDDD instruction was followed.</p><p><strong>Material and methods: </strong>All patients receiving MDDD on admission to the acute medical admission ward at Bispebjerg Hospital in the period from 1 January to 30 June 2010 were prospectively included in the study. An audit of the medication lists and hospital case records covering the period from admission to discharge was performed. A proportion of patients received a post-discharge home visit. An interview in both sectors was carried out to determine whether the instructions had been followed.</p><p><strong>Results: </strong>Almost 9% of the patients were receiving MDDD on admission. Information on MDDD was recorded in the physician case record for 3.4% of the patients and in the nurse case record for 12.9% of the patients. Changes in MDDD during hospitalization were made for 58.3% of the patients. General practitioners and/or the community pharmacy were notified of changes in MDDD at discharge for 13.6% of the patients. The post-discharge visits and the interview revealed potential issues of concern regarding patient safety.</p><p><strong>Conclusion: </strong>MDDD is frequent. Identification and registration of MDDD is only performed sporadically. Changes in MDDD are frequent, but they are rarely accompanied by information to the general practitioner or the community pharmacy.</p><p><strong>Funding: </strong>The project was partly funded by the Ministry of Health and Prevention 2009.</p><p><strong>Trial registration: </strong>The study was approved by the Danish Data Protection Agency.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"A4341"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue. 葡萄糖依赖性胰岛素多肽(GIP):从激素原到在内分泌、胰腺和脂肪组织中的作用。
Pub Date : 2011-12-01
Randi Ugleholdt

The present thesis consists of one published article and one draft manuscript. Interest in the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) was reignited by the discovery that GIP receptor deficient mice were unable to gain weight in response to high fat feeding. However, the path from processing of the prohormone to regulation of secretion and establishment of its role in the complicated network of mediators involved in energy mobilization is not fully understood. The biologically active GIP1-42 was found in vivo to be dependent on processing from the immature prohormone by proprotein convertase 1/3 (PC1/3) in the intestinal K-cell. Even so, ~50% of GIP immunoreactive cells do not express PC1/3 raising the possibility that subsets of K-cells exist in which the precursor may be cleaved at alternative sites. Cell line studies did demonstrate that another convertase in endocrine cell types, PC2, mediated cleavage at alternative sites liberating larger and smaller GIP fragments. It was possible to detect fragments of similar size in gel filtration extracts of murine upper jejunum, but the identity, mechanism of processing and function of these immunoreactivities remains uncertain. Once correctly processed GIP1-42 is secreted in response to food intake. The K-cell is believed to directly sense and respond to nutrients in the intestine, but as the molecular profiling of this cell type has just begun, the nutrient sensing machinery and possible feedback regulation are still poorly characterized. When secreted to the blood stream, GIP acts as a mediator of energy mobilization in a complex network with other hormones. An acute and established function of GIP is to exert its incretin function thereby enhancing glucose stimulated insulin secretion necessary for prompt disposal of nutrients, yet GIP also stimulates glucagon secretion to increase blood glucose. In the diabetic state the insulinotropic effect of GIP is impaired and an early inexpedient glucagon stimulation in response to a meal further counteracts effects of insulin and worsens glycaemic control. A demonstration that GIP receptor deficient mice were resistant to diet induced obesity let to the categorization of GIP as a fat promoting hormone and direct insulin-mimetic effects in adipose tissue has been proposed. We were able to demonstrate a redundancy for the GIP receptor in incorporation of lipids into adipocytes. We also observed that GIP receptor deficient mice could respond normally to high fat feeding with increased fat mass, but failed to increase lean mass. Mice with rescue of the GIP receptor in adipose tissue normalized the body composition in response to high fat diet, but the mice had a lower total body weight. In contrast, the GIP receptor expressed in the pancreatic beta-cell was able to promote lean mass gain on a low fat diet, but not on a high fat diet. Overall, we have established principal requirements for GIP maturation. Furthermore,

本论文由一篇已发表文章和一篇初稿组成。对肠促胰岛素激素葡萄糖依赖性胰岛素性多肽(GIP)的兴趣被重新点燃,因为发现GIP受体缺陷的小鼠在高脂肪喂养后无法增加体重。然而,从激素原的加工到调节分泌,以及其在参与能量动员的复杂介质网络中作用的确立,其途径尚不完全清楚。在体内发现具有生物活性的GIP1-42依赖于未成熟激素原在肠k细胞中被原蛋白转化酶1/3 (PC1/3)加工。即便如此,约50%的GIP免疫反应细胞不表达PC1/3,这增加了k细胞亚群存在的可能性,其中前体可能在其他位置被切割。细胞系研究确实表明,内分泌细胞类型中的另一种转化酶PC2介导了不同位点的裂解,释放出较大和较小的GIP片段。在小鼠上空肠凝胶过滤提取物中可以检测到类似大小的片段,但这些免疫反应的身份、加工机制和功能尚不清楚。一旦正确处理,GIP1-42就会根据食物摄入而分泌。k细胞被认为直接感知和响应肠道中的营养物质,但由于这种细胞类型的分子谱才刚刚开始,对营养物质感知机制和可能的反馈调节的描述仍然很差。当分泌到血液中时,GIP与其他激素在一个复杂的网络中作为能量动员的中介。GIP的一个急性和既定功能是发挥其肠促胰岛素功能,从而促进葡萄糖刺激胰岛素分泌,这是迅速处置营养物质所必需的,但GIP也刺激胰高血糖素分泌,以提高血糖。在糖尿病状态下,GIP的胰岛素促胰岛素作用受损,早期不适当的餐后胰高血糖素刺激进一步抵消胰岛素的作用,使血糖控制恶化。有研究表明,GIP受体缺陷小鼠对饮食性肥胖具有抗性,并将GIP归类为一种促脂激素,在脂肪组织中具有直接的胰岛素模拟作用。我们能够证明GIP受体在脂质结合到脂肪细胞中的冗余。我们还观察到,GIP受体缺陷小鼠对高脂肪喂养的反应正常,脂肪质量增加,但瘦质量没有增加。在脂肪组织中恢复GIP受体的小鼠在高脂肪饮食中使身体成分正常化,但小鼠的总体重较低。相比之下,胰腺β细胞中表达的GIP受体能够促进低脂肪饮食的瘦体重增加,但在高脂肪饮食中却没有。总的来说,我们已经建立了GIP成熟的主要需求。此外,我们已经证明β细胞和脂肪细胞的GIP受体表达都不能取代内源性GIP受体调节体重和身体组成。
{"title":"Glucose-dependent Insulinotropic Polypeptide (GIP): From prohormone to actions in endocrine pancreas and adipose tissue.","authors":"Randi Ugleholdt","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The present thesis consists of one published article and one draft manuscript. Interest in the incretin hormone glucose-dependent insulinotropic polypeptide (GIP) was reignited by the discovery that GIP receptor deficient mice were unable to gain weight in response to high fat feeding. However, the path from processing of the prohormone to regulation of secretion and establishment of its role in the complicated network of mediators involved in energy mobilization is not fully understood. The biologically active GIP1-42 was found in vivo to be dependent on processing from the immature prohormone by proprotein convertase 1/3 (PC1/3) in the intestinal K-cell. Even so, ~50% of GIP immunoreactive cells do not express PC1/3 raising the possibility that subsets of K-cells exist in which the precursor may be cleaved at alternative sites. Cell line studies did demonstrate that another convertase in endocrine cell types, PC2, mediated cleavage at alternative sites liberating larger and smaller GIP fragments. It was possible to detect fragments of similar size in gel filtration extracts of murine upper jejunum, but the identity, mechanism of processing and function of these immunoreactivities remains uncertain. Once correctly processed GIP1-42 is secreted in response to food intake. The K-cell is believed to directly sense and respond to nutrients in the intestine, but as the molecular profiling of this cell type has just begun, the nutrient sensing machinery and possible feedback regulation are still poorly characterized. When secreted to the blood stream, GIP acts as a mediator of energy mobilization in a complex network with other hormones. An acute and established function of GIP is to exert its incretin function thereby enhancing glucose stimulated insulin secretion necessary for prompt disposal of nutrients, yet GIP also stimulates glucagon secretion to increase blood glucose. In the diabetic state the insulinotropic effect of GIP is impaired and an early inexpedient glucagon stimulation in response to a meal further counteracts effects of insulin and worsens glycaemic control. A demonstration that GIP receptor deficient mice were resistant to diet induced obesity let to the categorization of GIP as a fat promoting hormone and direct insulin-mimetic effects in adipose tissue has been proposed. We were able to demonstrate a redundancy for the GIP receptor in incorporation of lipids into adipocytes. We also observed that GIP receptor deficient mice could respond normally to high fat feeding with increased fat mass, but failed to increase lean mass. Mice with rescue of the GIP receptor in adipose tissue normalized the body composition in response to high fat diet, but the mice had a lower total body weight. In contrast, the GIP receptor expressed in the pancreatic beta-cell was able to promote lean mass gain on a low fat diet, but not on a high fat diet. Overall, we have established principal requirements for GIP maturation. Furthermore, ","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"B4368"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short convalescence and minimal pain after out-patient Bascom's pit-pick operation. 门诊巴斯科姆挖穴手术后恢复时间短,疼痛最小。
Pub Date : 2011-12-01
Emilie Palmgren Colov, Claus Anders Bertelsen

Introduction: Treatment of pilonidal sinuses with Bascom's pit-pick operation can easily be performed under local analgesia. We describe pain during and after the operation, time to return to work, time to healing and success rate.

Material and methods: The study comprised a cohort of 75 primary pit-pick (PP) operations performed at our department between August 2007 and December 2009. The median age was 30 years (range 15-64 years) and 57 (76%) were male. A total of 55 patients were interviewed daily by phone for one week with a view to registering their ability to return to work and their scoring of maximum pain on a numerical rating scale with a pain score ranging from 0 (no pain) to 10.

Results: The mean maximum pain during the first post-operative day was 2.2 (95% confidence interval (CI) 1.8-2.7) and at day four 1.0 (CI 0.7-1.3). Within 24 hours, 51% could return to work and the mean time was 3.2 (CI 1.8-4.5) days. Postoperative infection was related to the presence of secondary sinus (p = 0.03) and increasing number of midline sinus excisions (p = 0.02). Complete wound healing was achieved in 84% of the patients after a mean period of 3.5 (CI 3.1-3.9) weeks. Incomplete wound healing was significantly related to a small number of PPs (p < 0.05), increasing number of midline sinus excisions (p < 0.05) and no postoperative infection (p = 0.01). At one-year follow-up 80% were considered successfully treated.

Conclusion: The majority of patients with simple pilonidal sinuses can be treated successfully with Bascom's PP procedure as out-patients. This regimen causes only mild postoperative pain and patients can resume work after a few days.

Funding: not relevant.

Trial registration: not relevant.

简介:在局部镇痛的情况下,采用巴斯科姆挖穴术治疗毛毛窦很容易。我们描述了手术期间和之后的疼痛,恢复工作的时间,愈合的时间和成功率。材料和方法:本研究包括2007年8月至2009年12月在我科进行的75例首次挖井(PP)手术。中位年龄为30岁(15-64岁),男性57例(76%)。共对55名患者进行了为期一周的电话访谈,目的是记录他们重返工作岗位的能力,以及他们在疼痛评分范围从0(无疼痛)到10的数值评定量表上的最大疼痛评分。结果:术后第一天的平均最大疼痛为2.2(95%可信区间(CI) 1.8-2.7),第四天的平均最大疼痛为1.0 (CI 0.7-1.3)。在24小时内,51%的患者可以恢复工作,平均时间为3.2天(CI 1.8-4.5)。术后感染与继发性鼻窦的存在(p = 0.03)和中线鼻窦切除次数的增加(p = 0.02)有关。84%的患者在平均3.5周(CI 3.1-3.9)后伤口完全愈合。伤口愈合不完全与PPs数量少(p < 0.05)、中线窦切除次数增加(p < 0.05)和术后无感染(p = 0.01)显著相关。在一年的随访中,80%的患者被认为成功治疗。结论:绝大多数单纯性毛窦患者均可作为门诊患者采用Bascom的PP手术治疗。这种疗法只会引起轻微的术后疼痛,患者几天后就可以恢复工作。资金:不相关。试验注册:不相关。
{"title":"Short convalescence and minimal pain after out-patient Bascom's pit-pick operation.","authors":"Emilie Palmgren Colov,&nbsp;Claus Anders Bertelsen","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Treatment of pilonidal sinuses with Bascom's pit-pick operation can easily be performed under local analgesia. We describe pain during and after the operation, time to return to work, time to healing and success rate.</p><p><strong>Material and methods: </strong>The study comprised a cohort of 75 primary pit-pick (PP) operations performed at our department between August 2007 and December 2009. The median age was 30 years (range 15-64 years) and 57 (76%) were male. A total of 55 patients were interviewed daily by phone for one week with a view to registering their ability to return to work and their scoring of maximum pain on a numerical rating scale with a pain score ranging from 0 (no pain) to 10.</p><p><strong>Results: </strong>The mean maximum pain during the first post-operative day was 2.2 (95% confidence interval (CI) 1.8-2.7) and at day four 1.0 (CI 0.7-1.3). Within 24 hours, 51% could return to work and the mean time was 3.2 (CI 1.8-4.5) days. Postoperative infection was related to the presence of secondary sinus (p = 0.03) and increasing number of midline sinus excisions (p = 0.02). Complete wound healing was achieved in 84% of the patients after a mean period of 3.5 (CI 3.1-3.9) weeks. Incomplete wound healing was significantly related to a small number of PPs (p < 0.05), increasing number of midline sinus excisions (p < 0.05) and no postoperative infection (p = 0.01). At one-year follow-up 80% were considered successfully treated.</p><p><strong>Conclusion: </strong>The majority of patients with simple pilonidal sinuses can be treated successfully with Bascom's PP procedure as out-patients. This regimen causes only mild postoperative pain and patients can resume work after a few days.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"A4348"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain and convalescence following laparoscopic ventral hernia repair. 腹腔镜腹疝修补术后的疼痛与康复。
Pub Date : 2011-12-01
Jens Ravn Eriksen

Severe pain is usual after laparoscopic ventral hernia repair (LVHR). Mesh fixation with titanium tacks may play a key role in the development of acute and chronic pain and alternative fixation methods should therefore be investigated. This PhD thesis was based on three studies and aimed too: 1) assess the intensity and impact of postoperative pain by detailed patient-reported description of pain and convalescence after LVHR (Study I), 2) evaluate the feasibility of fibrin sealant (FS) for mesh fixation in an experimental pig model (Study II), and 3) investigate FS vs. tacks for mesh fixation in LVHR in a randomised, double-blinded, clinical controlled study with acute postoperative pain as the primary outcome (Study III). In Study I - a prospective descriptive study - 35 patients were prospectively included and underwent LVHR. Scores of pain, quality of life, convalescence, fatigue, and general well-being were obtained from each patient. Follow-up was six months. Average pain from postoperative day (POD) 0-2 and POD 0-6 measured on a 0-100 mm visual analogue scale (VAS) was 61 and 48, respectively. Pain scores reached preoperative values at POD 30. The incidence of severe chronic pain was 7%. No parameter predicted postoperative pain significantly. Significant correlations were found between pain, and general well-being (rS= -0.8, p < 0.001), satisfaction (rS= -0.67, p < quality of life score (rS= -0.63, p < 0.001) six months postoperatively. Patients resumed normal daily activity at POD 14. In Study II - a randomised experimental study in pigs - nine pigs were operated laparoscopically with insertion of two different meshes fixed with either FS or tacks. All pigs were euthanized on POD 30. The primary outcome parameter was strength of ingrowth between the mesh and the anterior abdominal wall. A mechanical peel test was performed for each tissue sample. The secondary outcome parameters were grade and strength of adhesions to the mesh, shrinkage and displacement/folding of the mesh and histological parameters. All nine pigs survived without complications until sacrifice. No meshes were displaced from their initial position at autopsy, but in two cases mesh folding was observed. No significant difference in strength of ingrowth was found between different fixation methods or mesh types. Furthermore, no significant difference was found in grade or strength of adhesions or any histological parameters. In Study III - a randomised, controlled, double-blinded, multicenter trial - 40 patients with umbilical hernia defects between 1.5-5 cm, were randomly assigned to receive FS or titanium tacks for mesh fixation in LVHR. Patients, care givers and those assessing the outcomes were blinded to group assignment. The primary outcome was average pain from POD 0-2 (VAS score). Secondary outcome parameters were fatigue, general well-being and time to resume normal daily activity. Follow-up was one month for all. Patients in the FS group reported

重度疼痛是腹腔镜腹疝修复(LVHR)后常见的。钛钉网状固定可能在急性和慢性疼痛的发展中起关键作用,因此应该研究其他固定方法。这篇博士论文基于三项研究,目的也是:1)通过详细的患者报告的LVHR后疼痛和康复描述来评估术后疼痛的强度和影响(研究I), 2)评估纤维蛋白密封剂(FS)在实验猪模型中用于网状固定的可行性(研究II),以及3)在随机、双盲的LVHR中研究FS与钉钉的网状固定。以急性术后疼痛为主要结局的临床对照研究(研究III)。研究I是一项前瞻性描述性研究,前瞻性纳入35例患者并行LVHR。对每位患者进行疼痛评分、生活质量评分、康复评分、疲劳评分和总体幸福感评分。随访6个月。术后0-100 mm视觉模拟评分(VAS) 0-2和0-6日均疼痛分别为61和48。POD 30时疼痛评分达到术前值。重度慢性疼痛发生率为7%。没有参数能显著预测术后疼痛。术后6个月疼痛与总体幸福感(rS= -0.8, p < 0.001)、满意度(rS= -0.67, p <生活质量评分(rS= -0.63, p < 0.001)存在显著相关性。患者在POD 14恢复正常的日常活动。在第二项研究中——一项猪的随机实验研究——9头猪接受腹腔镜手术,植入两种不同的网片,用FS或大头针固定。所有猪均在POD 30上实施安乐死。主要结局参数是补片与前腹壁之间的生长强度。对每个组织样本进行机械剥离试验。次要结局参数是网片粘附的等级和强度,网片的收缩和位移/折叠以及组织学参数。所有9头猪在祭祀前都没有出现并发症。解剖时没有网格从初始位置移位,但在两例中观察到网格折叠。不同固定方式和网片类型间长入强度无显著差异。此外,在粘连的等级或强度或任何组织学参数上没有发现显著差异。研究III是一项随机、对照、双盲、多中心试验,40名脐疝缺陷在1.5-5厘米之间的患者被随机分配接受FS或钛钉用于LVHR的补片固定。患者、护理人员和评估结果的人员对小组分配不知情。主要终点为POD 0-2的平均疼痛(VAS评分)。次要结局参数是疲劳、总体幸福感和恢复正常日常活动的时间。随访时间为一个月。FS组患者在POD 0-2时报告的疼痛明显减轻(VAS中位数38(范围6-98)比60 (18-96),p = 0.01)。两组间的绝对VAS评分差异在活动时为20 mm (95% CI 4-35 mm),在休息时为19 mm (95% CI 3-34 mm)。与tack组相比,FS组患者报告POD 0-2和POD 0-10的不适明显减少。各组间疲劳评分无显著差异。两组间在住院时间、疝直径或麻醉后护理单元吗啡用量方面无显著差异。FS组患者在POD 7(1-66)恢复正常的日常活动,而tack组患者在POD 18(1-95)恢复正常活动(p = 0.03)。未见复发。未观察到不良事件或副作用。两组间预诊并发症无显著差异。总之,疼痛是LVHR术后显著的临床问题,影响患者的总体幸福感、生活质量和满意度。这一问题在今后腹疝修补研究中必须优先考虑。目前有文献报道,在缺陷< 5 cm的LVHR中,简单应用纤维蛋白胶代替钛钉进行补片固定,可显著减少急性疼痛、不适和恢复期。长期随访将显示FS固定在慢性疼痛和复发方面的价值。由于FS可能解决LVHR相关的许多预后问题,由于手术技术可能不同,未来的研究应包括更大的疝缺陷,包括大切口疝。
{"title":"Pain and convalescence following laparoscopic ventral hernia repair.","authors":"Jens Ravn Eriksen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Severe pain is usual after laparoscopic ventral hernia repair (LVHR). Mesh fixation with titanium tacks may play a key role in the development of acute and chronic pain and alternative fixation methods should therefore be investigated. This PhD thesis was based on three studies and aimed too: 1) assess the intensity and impact of postoperative pain by detailed patient-reported description of pain and convalescence after LVHR (Study I), 2) evaluate the feasibility of fibrin sealant (FS) for mesh fixation in an experimental pig model (Study II), and 3) investigate FS vs. tacks for mesh fixation in LVHR in a randomised, double-blinded, clinical controlled study with acute postoperative pain as the primary outcome (Study III). In Study I - a prospective descriptive study - 35 patients were prospectively included and underwent LVHR. Scores of pain, quality of life, convalescence, fatigue, and general well-being were obtained from each patient. Follow-up was six months. Average pain from postoperative day (POD) 0-2 and POD 0-6 measured on a 0-100 mm visual analogue scale (VAS) was 61 and 48, respectively. Pain scores reached preoperative values at POD 30. The incidence of severe chronic pain was 7%. No parameter predicted postoperative pain significantly. Significant correlations were found between pain, and general well-being (rS= -0.8, p < 0.001), satisfaction (rS= -0.67, p < quality of life score (rS= -0.63, p < 0.001) six months postoperatively. Patients resumed normal daily activity at POD 14. In Study II - a randomised experimental study in pigs - nine pigs were operated laparoscopically with insertion of two different meshes fixed with either FS or tacks. All pigs were euthanized on POD 30. The primary outcome parameter was strength of ingrowth between the mesh and the anterior abdominal wall. A mechanical peel test was performed for each tissue sample. The secondary outcome parameters were grade and strength of adhesions to the mesh, shrinkage and displacement/folding of the mesh and histological parameters. All nine pigs survived without complications until sacrifice. No meshes were displaced from their initial position at autopsy, but in two cases mesh folding was observed. No significant difference in strength of ingrowth was found between different fixation methods or mesh types. Furthermore, no significant difference was found in grade or strength of adhesions or any histological parameters. In Study III - a randomised, controlled, double-blinded, multicenter trial - 40 patients with umbilical hernia defects between 1.5-5 cm, were randomly assigned to receive FS or titanium tacks for mesh fixation in LVHR. Patients, care givers and those assessing the outcomes were blinded to group assignment. The primary outcome was average pain from POD 0-2 (VAS score). Secondary outcome parameters were fatigue, general well-being and time to resume normal daily activity. Follow-up was one month for all. Patients in the FS group reported ","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"B4369"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High morbidity after laparoscopic emergency colectomy for inflammatory bowel disease. 炎症性肠病腹腔镜紧急结肠切除术后的高发病率。
Pub Date : 2011-12-01
Saddiq Mohammad Qazi, Jan Skovdal, Lars Kristian Munck, Thue Bisgaard

Introduction: Only limited data are available on subtotal laparoscopic colectomy (STC) in patients with in inflammatory bowel disease. We present the first Danish experiences with intended laparoscopic STC for inflammatory bowel disease (IBD). The primary outcome was 30-day morbidity.

Material and methods: The present study is a retrospective single-centre study with consecutive enrolment of patients undergoing intended STC for IBD from 1 January 2005 to 31 July 2009. The results were analysed as either emergency or elective operations. Only the most severe complication was noted for each patient. Data on medical treatment, blood tests and complications and death within 30 days were registered.

Results: A total of 32 patients underwent surgery (15 elective and 17 emergency procedures). Patients in the emergency group had significantly more severe disease activity than elective patients. Severe complications were recorded in 47% and 20% of the patients undergoing emergency and elective STC, respectively (p = 0.15). The overall morbidity was 72%. One emergency patient died. Five of eight emergency patients and one of three elective patients underwent conversion and experienced a major complication (p = 0.55). The overall conversion rate was 32% (p = 0.15).

Conclusion: We found high morbidity and conversion rates in patients undergoing SLC for IBD. A prospective national Danish survey on early postoperative outcome is suggested.

Funding: not relevant.

Trial registration: not relevant.

只有有限的数据可用于炎性肠病患者的次全腹腔镜结肠切除术(STC)。我们提出了第一个丹麦的经验与预期腹腔镜STC炎性肠病(IBD)。主要终点为30天的发病率。材料和方法:本研究是一项回顾性单中心研究,从2005年1月1日至2009年7月31日,连续入组IBD患者接受STC治疗。结果分为急诊手术和择期手术进行分析。每位患者只记录最严重的并发症。登记了有关医疗、血液检查、并发症和30天内死亡的数据。结果:32例患者接受手术治疗(15例为择期手术,17例为急诊手术)。急诊组患者的疾病活动度明显高于非急诊组患者。47%的急诊STC患者和20%的择期STC患者出现严重并发症(p = 0.15)。总发病率为72%。一名急诊病人死亡。8名急诊患者中有5名和3名择期患者中有1名发生了转换并出现了主要并发症(p = 0.55)。总转化率为32% (p = 0.15)。结论:我们发现接受SLC治疗IBD患者的发病率和转换率很高。建议对早期术后结果进行前瞻性丹麦全国调查。资金:不相关。试验注册:不相关。
{"title":"High morbidity after laparoscopic emergency colectomy for inflammatory bowel disease.","authors":"Saddiq Mohammad Qazi,&nbsp;Jan Skovdal,&nbsp;Lars Kristian Munck,&nbsp;Thue Bisgaard","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Only limited data are available on subtotal laparoscopic colectomy (STC) in patients with in inflammatory bowel disease. We present the first Danish experiences with intended laparoscopic STC for inflammatory bowel disease (IBD). The primary outcome was 30-day morbidity.</p><p><strong>Material and methods: </strong>The present study is a retrospective single-centre study with consecutive enrolment of patients undergoing intended STC for IBD from 1 January 2005 to 31 July 2009. The results were analysed as either emergency or elective operations. Only the most severe complication was noted for each patient. Data on medical treatment, blood tests and complications and death within 30 days were registered.</p><p><strong>Results: </strong>A total of 32 patients underwent surgery (15 elective and 17 emergency procedures). Patients in the emergency group had significantly more severe disease activity than elective patients. Severe complications were recorded in 47% and 20% of the patients undergoing emergency and elective STC, respectively (p = 0.15). The overall morbidity was 72%. One emergency patient died. Five of eight emergency patients and one of three elective patients underwent conversion and experienced a major complication (p = 0.55). The overall conversion rate was 32% (p = 0.15).</p><p><strong>Conclusion: </strong>We found high morbidity and conversion rates in patients undergoing SLC for IBD. A prospective national Danish survey on early postoperative outcome is suggested.</p><p><strong>Funding: </strong>not relevant.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"A4326"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. 溃疡性结肠炎和克罗恩病妇女的出生结局,以及抗炎药物治疗的药物流行病学方面。
Pub Date : 2011-12-01
Bente Mertz Nørgård

The clinical epidemiological studies included in this thesis fall into three parts. The first part includes studies on birth outcome in women with ulcerative colitis. The second part includes pharmacoepidemiological studies on birth outcome after anti-inflammatory drug therapy in pregnancy, including patients with ulcerative colitis and Crohn's disease. The third part (and the latest publications) includes birth outcome in women with Crohn's disease; and the methods of cohort establishment in these studies are developed and improved due to the knowledge gathered from conducting the earlier studies. The birth outcomes in women with ulcerative colitis are examined in a nationwide, Danish, cohort of women based on data from the Danish National Hospital Discharge Registry and the Danish Medical Birth Registry, and within a Hungarian case-control data set. Our data suggest: 1) Significantly increased risk of preterm birth when women give birth 0-6 months after establishment of the diagnosis. It is considered whether the increased risk may be influenced by disease activity around the time of establishing the diagnosis. 2) No increased risk of giving birth to children with low birth weight, intrauterine growth retardation or congenital abnormalities (evaluated overall). 3) Significantly increased risk of some selected congenital abnormalities (limb deficiencies, obstructive urinary and multiple congenital abnormalities). No other studies have examined the risk of selected congenital abnormalities in children born by women with ulcerative colitis. The pharmacoepidemiological studies on birth outcomes after use of anti-inflammatory drug therapy in pregnancy, including women with ulcerative colitis and Crohn's disease, are based on data from the Hungarian case-control data set, a countywide Danish prescription Database, the Danish National Hospital Discharge Registry, the Danish Medical Birth Registry, and review of selected medical records. After exposure to sulfasalazine during pregnancy our data suggest. No significantly increased overall relative risk of congenital abnormalities and no significantly increased risks of selected congenital abnormalities. After exposure to 5-aminosalicylic acid during pregnancy our data suggest. No significantly increased relative risk of low birth weight, intrauterine growth retardation or congenital abnormalities (evaluated overall). A significantly increased relative risk of preterm birth and stillbirth in ulcerative colitis women, compared to women with no prescription of reimbursed medicine in pregnancy - and also after comparing with women with chronic inflammatory bowel disease not taking 5-aminosalicylic acid during pregnancy. It is not clear whether these associations are causal or influenced by confounding by disease activity in particular. After maternal exposure to azathioprine/6-mercaptopurine during pregnancy our data suggest. An increased relative risk of preterm birth, congenital abnormalit

本文的临床流行病学研究分为三个部分。第一部分包括对溃疡性结肠炎妇女分娩结局的研究。第二部分包括妊娠期抗炎药物治疗后出生结局的药物流行病学研究,包括溃疡性结肠炎和克罗恩病患者。第三部分(以及最新的出版物)包括克罗恩病妇女的出生结果;在这些研究中建立队列的方法由于从进行早期研究中收集的知识而得到发展和改进。溃疡性结肠炎妇女的出生结果是在丹麦全国范围内进行的,基于丹麦国家医院出院登记处和丹麦医学出生登记处的数据以及匈牙利病例对照数据集的妇女队列中进行的。我们的数据表明:1)诊断后0-6个月分娩的妇女早产风险显著增加。考虑到增加的风险是否可能受到确定诊断前后疾病活动的影响。2)生下低出生体重、宫内发育迟缓或先天性异常儿童的风险不增加(综合评估)。3)部分先天畸形(肢体缺陷、尿路梗阻性、多发性先天畸形)风险显著增加。没有其他的研究检查过溃疡性结肠炎妇女所生孩子的先天性异常风险。对妊娠期使用抗炎药物治疗后出生结果的药物流行病学研究,包括患有溃疡性结肠炎和克罗恩病的妇女,基于匈牙利病例对照数据集、丹麦全国处方数据库、丹麦国家出院登记、丹麦医疗出生登记和对选定医疗记录的审查。我们的数据表明,在怀孕期间接触磺胺嘧啶后。先天性异常的总体相对风险没有显著增加,某些先天性异常的风险也没有显著增加。在怀孕期间暴露于5-氨基水杨酸后,我们的数据表明。低出生体重、宫内发育迟缓或先天性异常的相对风险没有显著增加(总体评估)。溃疡性结肠炎妇女早产和死产的相对风险显著增加,与怀孕期间没有处方报销药物的妇女相比,也与怀孕期间没有服用5-氨基水杨酸的慢性炎症性肠病妇女相比。目前尚不清楚这些关联是因果关系还是受到疾病活动混淆的影响。孕妇在怀孕期间暴露于硫唑嘌呤/6-巯基嘌呤后,我们的数据表明。早产、先天性异常和围产期死亡率的相对风险增加-同样在使用具有类似基础疾病的对照组之后。很难排除不受控制的混杂因素的影响。这是一项针对慢性炎症性肠病暴露妇女的对照观察性研究首次发表的数据。在孕前父亲使用硫唑嘌呤/6-巯基嘌呤后,我们的数据显示先天性异常的风险增加,尽管没有显著增加。根据妊娠期间使用抗炎药物的类型,并根据丹麦国家医院出院登记处、丹麦全国处方数据库和丹麦医疗出生登记处的数据,在全国范围内对克罗恩病妇女的出生结果进行了检查。此外,根据对医院记录、丹麦国家医院出院登记处和丹麦医疗出生登记处的审查数据,对怀孕期间有疾病活动的克罗恩病妇女的出生结果进行了检查。我们的数据表明:1)克罗恩病妇女不良分娩结局的风险因妊娠期抗炎药物治疗的类型而异。2)根据使用磺胺氮嗪/5-氨基水杨酸或类固醇后的低出生体重、宫内生长迟缓、早产和先天性异常,结果令人放心。3)妊娠期服用硫唑嘌呤/6-巯基嘌呤后,早产风险显著增加,先天性异常风险增加(未显著增加)。在对早产的分析中,可能会留下一些由疾病活动引起的残留混淆。在妊娠期疾病活动度最高的克罗恩病妇女中,我们的数据表明:1)妊娠期疾病活动度最高的妇女早产的相对风险显著增加。 2)疾病活动似乎不会增加低出生体重、宫内生长迟缓或先天性异常的风险。本研究首次对妊娠期间有疾病活动的克罗恩病妇女与妊娠期间无疾病活动的克罗恩病妇女的不良出生结局风险进行了流行病学研究,并考虑了混杂因素。这篇论文超越了我之前博士论文的研究内容,在以下几个主题上提供了新的证据:1)溃疡性结肠炎妇女所生儿童出现特定先天性异常的风险,2)孕妇妊娠期接触硫唑嘌呤/6-巯基嘌呤后不良出生结局风险的药物流行病学研究,以及孕前接受硫唑嘌呤/6-巯基嘌呤治疗的男性所生儿童出现先天性异常的风险。iii)根据妊娠期抗炎药物治疗类型(磺胺氮嗪/5-氨基水杨酸、类固醇或硫唑嘌呤/6-巯基嘌呤),克罗恩病妇女不良分娩结局的风险,iv)克罗恩病妇女疾病活动对不良分娩结局的影响。我们从本论文的研究中了解到,传统的报告慢性炎症性肠病妇女分娩结果的方式,即没有关于基础疾病类型、同期治疗药物治疗和疾病活动的有效信息,价值有限。研究表明,患有溃疡性结肠炎和克罗恩病的妇女的特定不良分娩结果的风险取决于若干因素,包括与疾病的发病有关的出生时间、潜在疾病的类型(溃疡性结肠炎或克罗恩病)、怀孕期间抗炎药物治疗的类型以及怀孕期间疾病活动的程度。同时,我们也必须认识到,现有的证据仍然有限,特别是在怀孕期间治疗药物治疗后的生殖安全以及孕前治疗药物暴露可能产生的影响方面。
{"title":"Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.","authors":"Bente Mertz Nørgård","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The clinical epidemiological studies included in this thesis fall into three parts. The first part includes studies on birth outcome in women with ulcerative colitis. The second part includes pharmacoepidemiological studies on birth outcome after anti-inflammatory drug therapy in pregnancy, including patients with ulcerative colitis and Crohn's disease. The third part (and the latest publications) includes birth outcome in women with Crohn's disease; and the methods of cohort establishment in these studies are developed and improved due to the knowledge gathered from conducting the earlier studies. The birth outcomes in women with ulcerative colitis are examined in a nationwide, Danish, cohort of women based on data from the Danish National Hospital Discharge Registry and the Danish Medical Birth Registry, and within a Hungarian case-control data set. Our data suggest: 1) Significantly increased risk of preterm birth when women give birth 0-6 months after establishment of the diagnosis. It is considered whether the increased risk may be influenced by disease activity around the time of establishing the diagnosis. 2) No increased risk of giving birth to children with low birth weight, intrauterine growth retardation or congenital abnormalities (evaluated overall). 3) Significantly increased risk of some selected congenital abnormalities (limb deficiencies, obstructive urinary and multiple congenital abnormalities). No other studies have examined the risk of selected congenital abnormalities in children born by women with ulcerative colitis. The pharmacoepidemiological studies on birth outcomes after use of anti-inflammatory drug therapy in pregnancy, including women with ulcerative colitis and Crohn's disease, are based on data from the Hungarian case-control data set, a countywide Danish prescription Database, the Danish National Hospital Discharge Registry, the Danish Medical Birth Registry, and review of selected medical records. After exposure to sulfasalazine during pregnancy our data suggest. No significantly increased overall relative risk of congenital abnormalities and no significantly increased risks of selected congenital abnormalities. After exposure to 5-aminosalicylic acid during pregnancy our data suggest. No significantly increased relative risk of low birth weight, intrauterine growth retardation or congenital abnormalities (evaluated overall). A significantly increased relative risk of preterm birth and stillbirth in ulcerative colitis women, compared to women with no prescription of reimbursed medicine in pregnancy - and also after comparing with women with chronic inflammatory bowel disease not taking 5-aminosalicylic acid during pregnancy. It is not clear whether these associations are causal or influenced by confounding by disease activity in particular. After maternal exposure to azathioprine/6-mercaptopurine during pregnancy our data suggest. An increased relative risk of preterm birth, congenital abnormalit","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"B4360"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stagnation in body mass index in Denmark from 1997/1998 to 2004/2005, but with geographical diversity. 从1997/1998年到2004/2005年,丹麦的身体质量指数停滞不前,但存在地域差异。
Pub Date : 2011-12-01
Mathilde Svendstrup, Nils Jacob Knudsen, Torben Jørgensen, Lone Banke Rasmussen, Lars Ovesen, Hans Perrild, Peter Laurberg

Introduction: We analyzed the trend in body mass index (BMI) as well as in the prevalence of overweight and obesity among Danish adults, mainly women, from 1997/1998 to 2004/2005 and evaluated any regional differences.

Material and methods: Data were drawn from two cross-sectional population-based studies conducted in parallel in Aalborg and Copenhagen from 1997/1998 and 2004/2005. Height and weight were measured in a total of 7,487 participants in the two cohorts.

Results: In the total cohort, we found no significant difference in BMI from 1997/1998 to 2004/2005 (p = 0.828). There was an increase in BMI in Aalborg of 0.32 (p = 0.030), while in Copenhagen we observed a statistically significant decrease in BMI of 0.30 (p = 0.017). The difference in change over time in BMI between the two regions was significant (p = 0.002). Also the difference in the trend in prevalence of overweight and obesity was statistically significant between the two cities (p = 0.010).

Conclusion: Our results indicate that the obesity epidemic is leveling off - at least among women - and that it may even be receding in Copenhagen. Nevertheless, the absolute average BMI values and the prevalence of overweight and obesity in both cities are high which underlines the need for further initiatives to prevent obesity-related health risks in the future.

Funding: The DanThyr studies were supported by funding from the Tømmerhandler Vilhelm Bang Foundation, the Copenhagen Corporation Research Foundation, the 1991 Pharmacy Foundation, the Danish Medical Foundation, the Health Insurance Foundation, the Agnes and Knut Mørk Foundation, the Wedel Wedelsborg Foundation, the Ortho-Clinical Foundation and BRAHMS Diagnostica.

Trial registration: not relevant.

前言:我们分析了1997/1998至2004/2005年间丹麦成年人(主要是女性)体重指数(BMI)以及超重和肥胖患病率的趋势,并评估了任何地区差异。材料和方法:数据来自1997/1998年和2004/2005年在奥尔堡和哥本哈根平行进行的两项基于人口的横断面研究。研究人员测量了两组共7487名参与者的身高和体重。结果:在整个队列中,我们发现1997/1998年与2004/2005年BMI无显著差异(p = 0.828)。奥尔堡的BMI增加了0.32 (p = 0.030),而哥本哈根的BMI下降了0.30 (p = 0.017),具有统计学意义。两个地区BMI随时间的变化差异显著(p = 0.002)。此外,两个城市在超重和肥胖患病率趋势上的差异具有统计学意义(p = 0.010)。结论:我们的研究结果表明,肥胖的流行趋势正在趋于平稳——至少在女性中是这样——在哥本哈根甚至可能正在消退。然而,这两个城市的绝对平均BMI值以及超重和肥胖的流行率都很高,这突显出未来需要采取进一步措施预防与肥胖相关的健康风险。资助:DanThyr的研究得到了Tømmerhandler Vilhelm Bang基金会、哥本哈根公司研究基金会、1991药房基金会、丹麦医学基金会、健康保险基金会、Agnes and Knut Mørk基金会、Wedel Wedelsborg基金会、Ortho-Clinical基金会和BRAHMS Diagnostica的资助。试验注册:不相关。
{"title":"Stagnation in body mass index in Denmark from 1997/1998 to 2004/2005, but with geographical diversity.","authors":"Mathilde Svendstrup,&nbsp;Nils Jacob Knudsen,&nbsp;Torben Jørgensen,&nbsp;Lone Banke Rasmussen,&nbsp;Lars Ovesen,&nbsp;Hans Perrild,&nbsp;Peter Laurberg","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>We analyzed the trend in body mass index (BMI) as well as in the prevalence of overweight and obesity among Danish adults, mainly women, from 1997/1998 to 2004/2005 and evaluated any regional differences.</p><p><strong>Material and methods: </strong>Data were drawn from two cross-sectional population-based studies conducted in parallel in Aalborg and Copenhagen from 1997/1998 and 2004/2005. Height and weight were measured in a total of 7,487 participants in the two cohorts.</p><p><strong>Results: </strong>In the total cohort, we found no significant difference in BMI from 1997/1998 to 2004/2005 (p = 0.828). There was an increase in BMI in Aalborg of 0.32 (p = 0.030), while in Copenhagen we observed a statistically significant decrease in BMI of 0.30 (p = 0.017). The difference in change over time in BMI between the two regions was significant (p = 0.002). Also the difference in the trend in prevalence of overweight and obesity was statistically significant between the two cities (p = 0.010).</p><p><strong>Conclusion: </strong>Our results indicate that the obesity epidemic is leveling off - at least among women - and that it may even be receding in Copenhagen. Nevertheless, the absolute average BMI values and the prevalence of overweight and obesity in both cities are high which underlines the need for further initiatives to prevent obesity-related health risks in the future.</p><p><strong>Funding: </strong>The DanThyr studies were supported by funding from the Tømmerhandler Vilhelm Bang Foundation, the Copenhagen Corporation Research Foundation, the 1991 Pharmacy Foundation, the Danish Medical Foundation, the Health Insurance Foundation, the Agnes and Knut Mørk Foundation, the Wedel Wedelsborg Foundation, the Ortho-Clinical Foundation and BRAHMS Diagnostica.</p><p><strong>Trial registration: </strong>not relevant.</p>","PeriodicalId":11019,"journal":{"name":"Danish medical bulletin","volume":"58 12","pages":"A4344"},"PeriodicalIF":0.0,"publicationDate":"2011-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30303580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Danish medical bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1